Back to top
more

Neogen (NEOG)

(Real Time Quote from BATS)

$10.04 USD

10.04
1,945,885

-0.30 (-2.90%)

Updated Apr 9, 2026 11:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.93%
2Buy18.12%
3Hold10.10%
4Sell5.65%
5Strong Sell2.94%
S&P50011.36%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (153 out of 244)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended February 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Neogen (NEOG) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Neogen (NEOG) delivered earnings and revenue surprises of +125.00% and +3.30%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Countdown to Neogen (NEOG) Q3 Earnings: Wall Street Forecasts for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Neogen (NEOG) for the quarter ended February 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline

by Zacks Equity Research

Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Jushi Holdings Inc. (JUSHF) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of -33.33% and +1.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -125.00% and -1.16%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Verano Holdings Corp. (VRNO) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNO) delivered earnings and revenue surprises of -66.67% and +0.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

by Zacks Equity Research

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Zacks Equity Research

Company News for Jan 9, 2026

by Zacks Equity Research

Companies in The News Are: LMT, SMPL, GOOGL, AAPL, NEOG

Zacks Equity Research

Compared to Estimates, Neogen (NEOG) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.